? CORE B The Cell and Molecular Core (Core B) laboratories, physically located at St. Jude Children?s Research Hospital (SJCRH), includes the central Sample Accessioning laboratory and the Molecular Analysis laboratory for the 3 research projects. Samples (ALL samples, normal blood or bone marrow samples, RNA or DNA) will come to the Sample Accessioning laboratory from multiple sources: the Children?s Oncology Group (COG), Alliance for Clinical Trials in Oncology, Eastern Cooperative Oncology Group (ECOG/ACRIN), MD Anderson, Erasmus University, and SJCRH. Samples are accessioned, labelled, and tracked electronically. ALL cell samples are provided to Project 2 for in vitro drug sensitivity. DNA and RNA samples are sent to the Molecular Analysis laboratory for molecular profiling in support of the Aims of each project, to include single nucleotide polymorphism (SNP) arrays to analyze DNA copy number and SNP genotypes in both germline and ALL cells, whole exome sequencing (WES) of both germline and ALL cells, transcriptome sequencing (RNA-seq) of ALL cells, CpG methylation arrays to analyze ALL cells, and exome SNP arrays to analyze rare coding variants in germline samples. Core B facilitates sample tracking and cross-project data sharing by curation of sample meta-data to a centralized data warehouse, GDBALL (Genomic DataBase for ALL), tracking what assays have been done for all samples, by whom, and where the raw data are. Core B provides retrievals on the status of molecular assays for samples to assess success in meeting milestones for all three projects, set by Core A, and to provide feedback to Project investigators and to the participating cell banks of COG, ECOG, Alliance, MD Anderson, and Erasmus on status of their samples. Core B is responsible for making and tracking data deposits in public databases. By centralizing each of these functions, Core B provides an efficient resource for basic quality control of the genome-wide data for this Center. Core B will ensure that each project generates high quality data for secondary and tertiary data analyses that will be performed by the Bioinformatics and Biostatistics Core (Core C).

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Specialized Center (P50)
Project #
5P50GM115279-04
Application #
9509474
Study Section
Special Emphasis Panel (ZGM1)
Project Start
Project End
Budget Start
2018-07-01
Budget End
2019-06-30
Support Year
4
Fiscal Year
2018
Total Cost
Indirect Cost
Name
St. Jude Children's Research Hospital
Department
Type
DUNS #
067717892
City
Memphis
State
TN
Country
United States
Zip Code
38105
Nishii, Rina; Moriyama, Takaya; Janke, Laura J et al. (2018) Preclinical evaluation of NUDT15-guided thiopurine therapy and its effects on toxicity and antileukemic efficacy. Blood 131:2466-2474
Pui, Ching-Hon; Liu, Yiwei; Relling, Mary V (2018) How to solve the problem of hypersensitivity to asparaginase? Pediatr Blood Cancer 65:
Zhang, Yingchi; Gao, Yufeng; Zhang, Hui et al. (2018) PDGFRB mutation and tyrosine kinase inhibitor resistance in Ph-like acute lymphoblastic leukemia. Blood 131:2256-2261
Gupta, Sumit; Devidas, Meenakshi; Loh, Mignon L et al. (2018) Flow-cytometric vs. -morphologic assessment of remission in childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group (COG). Leukemia 32:1370-1379
Steeghs, Elisabeth M P; Bakker, Marjolein; Hoogkamer, Alex Q et al. (2018) High STAP1 expression in DUX4-rearranged cases is not suitable as therapeutic target in pediatric B-cell precursor acute lymphoblastic leukemia. Sci Rep 8:693
Diouf, Barthelemy; Lin, Wenwei; Goktug, Asli et al. (2018) Alteration of RNA Splicing by Small-Molecule Inhibitors of the Interaction between NHP2L1 and U4. SLAS Discov 23:164-173
Pui, Ching-Hon (2018) To delay or not to delay, that is the question for patients with acute lymphoblastic leukemia who do not receive prophylactic cranial irradiation. Cancer 124:4442-4446
Churchman, Michelle L; Qian, Maoxiang; Te Kronnie, Geertruy et al. (2018) Germline Genetic IKZF1 Variation and Predisposition to Childhood Acute Lymphoblastic Leukemia. Cancer Cell 33:937-948.e8
Browne, Emily K; Zhou, Yinmei; Chemaitilly, Wassim et al. (2018) Changes in body mass index, height, and weight in children during and after therapy for acute lymphoblastic leukemia. Cancer 124:4248-4259
Diouf, Barthelemy; Evans, William E (2018) Pharmacogenomics of Vincristine-Induced Peripheral Neuropathy: Progress Continues. Clin Pharmacol Ther :

Showing the most recent 10 out of 72 publications